Building For the Future: New Investments in KCAS

Even while many in the industry have pulled back on growth and expansion efforts after COVID's years-long effect on business and supply lines worldwide, KCAS is in a unique position - as a result of many years of sound decision making and customer relationship building - to expand its operations into an all-new facility full of state-of-the-art equipment and technology throughout. During this month's episode of podcast, Dom and John talk a bit about what everyone can expect as they see KCAS move into these beautiful new facilities during the summer of 2022!"The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks. The Weekly Bioanalysis is brought to you by KCAS.KCAS is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA and Milan, Italy, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.